Aardvark Therapeutics (NASDAQ:AARD) Coverage Initiated by Analysts at Morgan Stanley
Morgan Stanley started coverage on shares of Aardvark Therapeutics (NASDAQ:AARD – Free Report) in a research note released on Monday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $29.00 price objective on the stock. A number of other brokerages also recently commented on AARD. Royal Bank of Canada began coverage on Aardvark […]
Morgan Stanley started coverage on shares of Aardvark Therapeutics (NASDAQ:AARD – Free Report) in a research note released on Monday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $29.00 price objective on the stock. A number of other brokerages also recently commented on AARD. Royal Bank of Canada began coverage on Aardvark […]
